# NCT07126158 (NCT07126158)

> Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT07126158
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: Washington University School of Medicine
- Conditions: Pancreatic Adenocarcinoma; Cancer of the Pancreas; Pancreas Cancer; Pancreatic Cancer
- Interventions: Stereotactic body radiotherapy; Defactinib; Avutometinib
- Enrollment: 36
- Primary outcome: Progression-free survival (PFS) - Experimental Arm Only

## Indexed commentary on NCT07126158 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct07126158